Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
Pfizer-sponsored real-world study evaluating Ritlecitinib in adults with severe alopecia areata has completed.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s) [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, pharmacodynamics, pharmacokinetics, and immunogenicity of VIS171 in partici…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of oral roflumilast compared with intralesional corticosteroid injections for alopecia ar…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Intralesional Cyclosporine for Alopecia Areata [EARLY_Phase 1]
A clinical trial is evaluating intralesional cyclosporine for alopecia areata in an early Phase 1 study. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata [Phase 2]
Phase 2 clinical trial evaluating microbiota transplant therapy for alopecia areata and related conditions is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
This update describes a clinical trial evaluating stigma toward patients with alopecia areata, atopic dermatitis, vitiligo, and psoriasis, c…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Long-Term PF-06651600 for the Treatment of Alopecia Areata [Phase 3]
Pfizer completed a long-term Phase 3 trial of PF-06651600 for alopecia areata. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation
Completed clinical trial evaluating the safety and effectiveness of Rhofanib (tofacitinib) for alopecia areata and its severe forms, alopeci…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Regeneron AA Multicenter (Dupilumab) [Phase 2]
Regeneron's dupilumab is being studied in a multicenter Phase 2 trial for Alopecia Areata. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Determinants of Chronic Inflammatory Skin Disease Trajectories
An ongoing clinical study is investigating determinants of chronic inflammatory skin disease trajectories, spanning multiple conditions such…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
This clinical trial update summarizes the impact of untreated depression and anxiety on patients with skin diseases in Jeddah, Saudi Arabia.…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Healthcare Disparities in Alopecia Areata
A clinical trial update reports completed results on healthcare disparities in alopecia areata. The study, sponsored by Momentum Data, has p…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases [NA]
A completed clinical trial conducted by Universitätsklinikum Hamburg-Eppendorf evaluating an online intervention to reduce self-stigma in pe…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients [Phase 2]
Phase 2 trial to evaluate the safety and efficacy of SYHX1901 tablets in severe alopecia areata; the study is not yet recruiting.
-
EMA withdrawal · 2025-05-26EMA Application withdrawn: Cinainu (dry aqueous extract of paullinia cupana seed;dry hydroethanolic extract of theobroma cacao seed;liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit) — Legacy Healthcare (France) S.A.S.
The European Medicines Agency has withdrawn the marketing authorization application for Cinainu for alopecia areata.
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata [Phase 2]
A Phase 2 study of EQ101 in adults with moderate-to-severe alopecia areata has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata [Phase 3]
This update covers the extension Phase 3 trial of Jaktinib in adults with Alopecia Areata, evaluating safety and efficacy. The study status …
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata [Phase 3]
Phase 3 clinical trial update showing the safety and efficacy evaluation of Jaktinib in adults with alopecia areata; the study has completed…
-
EMA approval · 2025-03-03EMA Authorised: Litfulo (ritlecitinib tosilate) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Litfulo (ritlecitinib tosilate) from Pfizer Europe MA EEIG for the treatment of alopecia areata in …
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata [Phase 2]
Phase 2 trial evaluating the efficacy and safety of deucravacitinib in participants with alopecia areata was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. [Phase 2]
Clinical trial update on the efficacy of twice-daily LEO 124249 ointment 30 mg/g for eyebrow alopecia areata in a Phase 2 study that was ter…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias [NA]
A terminated clinical trial from the University of Minnesota evaluated a mechanical intervention targeting the scalp microbiome for cicatric…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Psychosocial Stress on QOL in Saudi Arabian Patients With Alopecia Areata
This clinical trial update shows that the study on psychosocial stress and quality of life in Saudi Arabian patients with Alopecia Areata ha…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study [Phase 2]
This is a Phase 2 prospective open-label study evaluating the effectiveness and tolerability of Baricitinib for acute Alopecia Areata with a…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata [Phase 2]
A Phase 2 trial completed comparing weekly azathioprine pulse to betamethasone oral mini-pulse for moderate-to-severe alopecia areata to eva…